Trial intelligence / Profile preview

Rosuvastatin on HDL2 in Chinese CAD Patients

NCT02593487Phase 4Unknown

Start
Nov 2015
Primary completion
Dec 2016
Countries
1
01

Overview

A Phase 4 trial of rosuvastatin in hyperlipidemia, coronary artery disease (CAD). Status: unknown.

02

Drugs

rosuvastatin
03

Conditions

hyperlipidemiacoronary artery disease (CAD)

Beyond the preview

Go deeper on NCT02593487.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02593487.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call